SLC6A3 and Parkinson disease: Similarly, 5-year longitudinal data on the change of clinical and DAT imaging outcomes measures in early, untreated PD patients from the PPMI cohort showed only a weak correlation between MDS-UPDRS-III and DAT binding, most marked at baseline, but no correlation between the rate of change of the 2 variables [70].